Another big-ticket IPO in the works. The Rs 3,395 crore Anthem Biosciences IPO will open next Monday. A book-built issue, it is a pure offer for sale with no fresh issue component. Anthem Biosciences, a CDMO play, has fully integrated operations encompassing drug discovery, development, and manufacturing processes.